AT ABBVIE, WE ARE STRIVING TO OUTSMART CANCER. TOGETHER.

AbbVie is focused on delivering treatments in oncology that will have a remarkable impact on the lives of people affected by cancer around the world.

AbbVie is striving to outsmart cancer by working with scientists, physicians, industry peers, patient groups and most importantly patients, to discover, develop and provide new therapies that will have a remarkable impact on the lives of people around the world affected by cancer. Our goal is to provide medicines that lead to improvement in cancer treatment and outcomes for cancer patients. By exploring and investing in new pathways, technologies and approaches, AbbVie is breaking ground in some of the most widespread and difficult-to-treat cancers. Together, we are striving to outsmart cancer.

oncology-home

INNOVATION

AbbVie has a deep heritage in oncology research and the technology and approaches we are taking to advance cancer treatment are becoming foundational to the next generation of cancer treatment. We research, validate, and target specific molecular pathways, allowing us to discover and develop innovative cancer therapies that aim to disrupt the natural progression of cancer cells. Our efforts combine a deep understanding of how cancer works with state-of-the-art technologies to deliver smarter solutions faster to the oncology community. LEARN MORE »

Expertise

The best science comes from the best scientists and AbbVie’s scientists and researchers are utilizing their deep expertise to explore novel mechanisms of action and administration to disrupt cancer development and growth across multiple tumor types. LEARN MORE »

COLLABORATION

At AbbVie, we work closely with scientists, physicians, industry peers, patient groups and most importantly patients to develop medicines that aim to transform the way cancer is treated. It is this intense focus on collaboration to bring together the best and smartest minds in oncology that will help in our commitment to outsmart cancer. LEARN MORE »

Commitment

With our pioneering spirit, collaborative nature, resources and expertise, AbbVie hopes to improve the lives of people around the world affected by cancer. LEARN MORE »




GBL/ONC/0316/0342

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?